載入...
Systemic therapy for advanced renal cell carcinoma
Renal cell carcinoma (RCC) accounts for approximately 3% of all cancers and is refractory to cytotoxic chemotherapy – immunotherapy has until recently been the standard of care for advanced disease. Randomised trials reported in the last 5 years have demonstrated that a number of agents including th...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3125990/ https://ncbi.nlm.nih.gov/pubmed/21789110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834009338430 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|